Advertisement
Canada markets closed
  • S&P/TSX

    22,290.62
    +31.15 (+0.14%)
     
  • S&P 500

    5,187.70
    +6.96 (+0.13%)
     
  • DOW

    38,884.26
    +31.99 (+0.08%)
     
  • CAD/USD

    0.7278
    -0.0009 (-0.12%)
     
  • CRUDE OIL

    78.26
    -0.12 (-0.15%)
     
  • Bitcoin CAD

    86,044.72
    -1,312.02 (-1.50%)
     
  • CMC Crypto 200

    1,297.36
    -67.77 (-4.96%)
     
  • GOLD FUTURES

    2,321.90
    -2.30 (-0.10%)
     
  • RUSSELL 2000

    2,064.65
    +3.97 (+0.19%)
     
  • 10-Yr Bond

    4.4630
    -0.0260 (-0.58%)
     
  • NASDAQ futures

    18,210.00
    +10.50 (+0.06%)
     
  • VOLATILITY

    13.23
    -0.26 (-1.93%)
     
  • FTSE

    8,313.67
    +100.18 (+1.22%)
     
  • NIKKEI 225

    38,410.28
    -424.82 (-1.09%)
     
  • CAD/EUR

    0.6770
    -0.0001 (-0.01%)
     

Compared to Estimates, Centene (CNC) Q1 Earnings: A Look at Key Metrics

For the quarter ended March 2024, Centene (CNC) reported revenue of $40.41 billion, up 3.9% over the same period last year. EPS came in at $2.26, compared to $2.11 in the year-ago quarter.

The reported revenue represents a surprise of +10.97% over the Zacks Consensus Estimate of $36.41 billion. With the consensus EPS estimate being $2.09, the EPS surprise was +8.13%.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

ADVERTISEMENT

Here is how Centene performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Total Medical Health (Benefits) loss Ratios -Total Ratio (HBR): 87.1% versus the five-analyst average estimate of 87.1%.

  • Membership Medicaid - High Acuity Medicaid: 1,547.6 thousand versus the three-analyst average estimate of 1,737.68 thousand.

  • Membership by line of business - Medicaid: 13,297.6 thousand versus 13,589.05 thousand estimated by three analysts on average.

  • SG&A Expense Ratio: 8.9% versus 8.7% estimated by three analysts on average.

  • Revenues- Premium and service revenues: $36.34 billion versus the five-analyst average estimate of $34.07 billion. The reported number represents a year-over-year change of +4%.

  • Revenues- Premium: $35.53 billion versus $33.07 billion estimated by five analysts on average. Compared to the year-ago quarter, this number represents a +5% change.

  • Revenues- Service: $808 million versus the five-analyst average estimate of $993.85 million. The reported number represents a year-over-year change of -28.3%.

  • Revenues- Premium tax: $4.07 billion versus the five-analyst average estimate of $2.52 billion.

  • Revenues- Premium and service revenues- Commercial: $7.75 billion versus $7.89 billion estimated by three analysts on average.

  • Revenues- Premium and service revenues- Medicare: $5.94 billion compared to the $5.31 billion average estimate based on three analysts.

  • Revenues- Premium and service revenues- Medicaid: $21.46 billion versus the three-analyst average estimate of $20.75 billion. The reported number represents a year-over-year change of -3.5%.

  • Revenues- Premium and service revenues- Other: $1.19 billion versus the two-analyst average estimate of $1.42 billion. The reported number represents a year-over-year change of -25.4%.

View all Key Company Metrics for Centene here>>>

Shares of Centene have returned -3.6% over the past month versus the Zacks S&P 500 composite's -3.2% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Centene Corporation (CNC) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research